logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Figure GPS-18. Overview of drug prevalence estimates from various studies in Europe for all adults (aged 15 to 64) and young adults (aged 15 to 34) [see all figures in this series...]

Part (ii) Cocaine, amphetamines and ecstasy use – lifetime experience, last year and last month prevalence


The chart shows the overall average of the relevant studies, weighted by sample size.


SB2006: Figure GPS-33 part (ii).

See also Table GPS-0.

For details of the studies included see Tables GPS-1 to GPS-6

See also 'General notes for interpreting data' on the Explanatory notes and help page.


Reitox national reports 2006, taken from population surveys, reports or scientific articles.

Page last updated: Wednesday, 21 November 2007